Search Results 101-110 of 13275 for Refractive errors

  1. Mayo Clinic Department of Ophthalmology - Doctors

    Tran, O.D.. Optometrist. Jacksonville, FL. Areas of focus: Contact lens fitting, Keratoconus, Dry eyes, Refractive error. Barbara K ...

  2. Mayo Clinic Department of Ophthalmology - Doctors

    Tran, O.D.. Optometrist. Jacksonville, FL. Areas of focus: Contact lens fitting, Keratoconus, Dry eyes, Refractive error. Barbara K ...

  3. HTS1 - Mayo Clinic

    Refractive error between +3.00D and +6.00D SE (by cycloplegic refraction) in either eye; Astigmatism <1.50D in both eyes; Spherical equivalent anisometropia ...

  4. Mayo Clinic Minute Do you make these sunscreen errors? VIDEO AUDIO Sound of sunscreen bottle being opened Sound of sunscreen squ

    VIDEO. AUDIO. Sound of sunscreen bottle being opened. Sound of sunscreen squirting into a glass. If this looks like a lot of sunscreen, then you might.

  5. Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Clinical Trials · Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer · More about research at Mayo Clinic · Mayo ...

  6. Publications - Brian G. Mohney, M.D. - Mayo Clinic

    Complications, Visual Acuity, and Refractive Error 3 Years after Secondary Intraocular Lens Implantation for Pediatric Aphakia. Ophthalmology. 2024 Oct; 131 ...

  7. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

    This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia ...

  8. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma · Share · Facebook · Twitter.

  9. Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs - Mayo Clinic

    The study will enroll low risk MDS patients who need red blood cell transfusions and who are refractory to or are not using erythropoiesis-stimulating agents.

  10. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

    Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. Participation eligibility.